Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Sphingosine-1-phosphate Receptor 1 (S1P1 ) Signaling in T cells: Trafficking and Beyond.
DGPPN guideline on anxiety disorders and cognitive dysfunction in the elderly or patients with multiple sclerosis.
Pixantrone: a B-cell-depleting immunosuppressant for multiple sclerosis patients with active disease.
Chronic Pain in Multiple Sclerosis Patients: Utility of Sensory Quantitative Testing in Patients with Fibromyalgia Comorbidity.
The pathology of multiple sclerosis is the result of focal inflammatory demyelination with axonal damage.
Microcystic Macular Edema: Retrograde Maculopathy Caused by Optic Neuropathy.
Potential of Urinary Metabolites for Diagnosing Multiple Sclerosis.
Acupuncture and multiple sclerosis: a review of the evidence.
Mind the gap! Lay and medical perceptions of risks associated with the use of alternative treatment and conventional medicine.
Role of regulatory T cells in pathogenesis and biological therapy of multiple sclerosis.
Long-term risk of malignancy after treatment of inflammatory bowel disease with azathioprine.
Higher Circulating Levels of Chemokine CCL20 in Patients with Multiple Sclerosis: Evaluation of the Influences of Chemokine Gene Polymorphism, Gender, Treatment and Disease Pattern.
Diffusion tensor imaging of optic nerve and optic radiation in primary chronic angle-closure glaucoma using 3T magnetic resonance imaging.
Comprehensive analysis of human endogenous retrovirus group HERV-W locus transcription in multiple sclerosis brain lesions by high throughput amplicon sequencing.
[Multiple sclerosis and pelviperineology: Urinary and sexual dysfunctions and pregnancy].
Chemokine receptor expression by inflammatory T cells in EAE.
Fatigue, Sleep Quality, and Disability in Relation to Quality of Life in Multiple Sclerosis.
Does long-term partial sodium channel blockade alter disease progression in MS? Evidence from a retrospective study.
A Bayesian hierarchical surrogate outcome model for multiple sclerosis.
Predictors of effectiveness of multidisciplinary rehabilitation treatment on motor dysfunction in multiple sclerosis.
Ciglitazone, a peroxisome proliferator-activated receptor gamma ligand, inhibits proliferation and differentiation of th17 cells.
Long-term effects of intrathecal baclofen in multiple sclerosis.
What is new in MS spasticity research? Poster session highlights.
Gain of Olig2 function in oligodendrocyte progenitors promotes remyelination.
Long-term assessment of No Evidence of Disease Activity with natalizumab in relapsing multiple sclerosis.
Pages
« first
‹ previous
…
504
505
506
507
508
509
510
511
512
…
next ›
last »